Low-Volume Manufacturing: CNC Machining & Short-Run Injection Molding Vs Mass Production

Moving from a validated prototype to manufacturing creates a difficult question for hardware teams: How much production should you commit to right now?

A lower unit price can make mass production look like the obvious answer. But mass production often requires a larger tooling investment, a more stable design, predictable demand, and confidence that you will not need significant changes after production begins.

That makes it risky for startups launching their first product, engineering teams testing a new product line, and manufacturers serving specialized markets.

Low volume manufacturing gives these teams another route. Instead of committing straight to high-volume tooling and a large inventory, you can produce smaller batches using CNC machining or short-run injection molding. You get production-ready parts while keeping room to respond to engineering changes, customer feedback, and real demand as it shows up.

The question worth asking is not just how many parts you need. It is how mature your design actually is, what material the part needs, how tight the tolerances run, how confident you are in demand, and what it costs you if something changes after you commit.

Low volume manufacturing is the production of functional or end-use parts in quantities that do not yet justify the tooling, automation, inventory, or infrastructure associated with mass production.

There is no universal quantity that defines "low volume."

For one product, several hundred units may justify injection molding. For another, machining several thousand parts may still make economic sense. Product geometry, tooling complexity, material, demand, and required manufacturing process all affect the decision.

The purpose matters more than a fixed number.

A startup may use low volume manufacturing for an initial commercial launch. An engineering team may need it for a specialized product variant. A medical device company may use controlled production batches during development, verification, validation, or early market introduction.

Prototyping primarily answers one question:

A prototype helps teams evaluate form, fit, function, ergonomics, assembly, or specific engineering assumptions. It may use 3D printing, CNC machining, fabricated parts, or alternative materials depending on what needs to be tested.

Low-volume manufacturing comes closer to production intent. The goal is no longer just to prove that the product works, but to manufacture usable parts consistently across a batch.

At this stage, teams usually start paying closer attention to production materials, tolerances, inspection requirements, DFM, assembly methods, and manufacturing repeatability.

In simple terms, a prototype proves that you can make the product. Low volume manufacturing starts proving that you can make it consistently.

Mass production focuses on producing large quantities as efficiently and consistently as possible, usually with the lowest practical unit cost.

To achieve that, manufacturers may invest heavily in injection molds, dedicated fixtures, automated processes, multi-cavity tooling, and production-specific equipment. Those upfront costs make sense when they can be spread across a large and predictable production run.

Low volume manufacturing makes a different trade-off.

It usually accepts a higher cost per part in exchange for lower upfront investment, greater design flexibility, and less inventory exposure.

That can be valuable when demand is still developing, the design may require further refinement, or the business is not yet ready to commit to full-scale tooling.

So the main difference is not simply small quantity versus large quantity. It is the level of manufacturing commitment that makes sense for the product at its current stage.

Going straight to mass production assumes the design is stable and demand is predictable. For many hardware products, neither is fully certain yet.

Low volume manufacturing lets teams increase production commitment gradually while they validate the product, market demand, and manufacturing process.

A product can perform well during testing and still reveal issues after launch. Customers may request changes, installers may find assembly problems, or field use may expose concerns around wear, serviceability, sealing, thermal performance, or usability.

Producing smaller batches limits how much inventory and capital are exposed to these uncertainties. Teams can learn from early production and apply those findings to the next batch instead of committing thousands of units to an assumption.

Low volume processes usually give engineers more room to change the product.

With CNC machining, teams can update the CAD model, revise CAM programming, and manufacture the next version without replacing a dedicated mold.

Injection molding becomes less flexible once tooling exists. Changes may require machining the mold, adding inserts, modifying cores, or in some cases replacing the tool.

The key point is simple: design changes usually become more expensive after tooling begins.

A lower unit price does not always mean a lower total cost.

A large production run may require higher tooling investment, more inventory, storage, and greater exposure if demand falls or the design changes.

Low volume manufacturing may cost more per part, but it reduces the size of the overall commitment.

For an evolving product, that can make a higher piece price financially safer than chasing the lowest possible unit cost too early.

CNC machining produces parts directly from digital CAD and CAM data without requiring a dedicated production mold. That makes it particularly useful when quantities are still relatively low, tolerances matter, or the design may continue to evolve.

Often, yes.

If engineers change a mounting point, pocket, interface, or other feature, the manufacturer can update the machining program and produce the revised version without reworking an injection mold.

Changes can still affect cost if they require new fixtures, additional setups, different tools, or longer machining time. But the commitment is usually lower than changing completed mold tooling.

That makes CNC a strong option during engineering validation, early production, and other stages where the product works but still needs refinement.

CNC machining works well when parts require tight dimensional control, precision holes or bores, threaded features, accurate mating surfaces, or structural performance.

It also supports a wide range of metals and engineering plastics, which is valuable when the part must behave like the intended production component rather than simply represent its shape.

Typical applications include functional housings, precision mechanical parts, fixtures, mounting components, and low-volume structural parts.

However, machinability still depends on good DFM. Deep pockets, difficult tool access, excessive setups, or unnecessarily tight tolerances can increase machining time and cost even when the part is technically manufacturable.

Every CNC part costs machine time. The machine loads the stock, removes material, swaps tools, and runs each operation, and someone still needs to deburr, inspect, and finish the part afterward.

Programming and fixture costs spread across more parts as quantity increases, and better workholding or production planning can reduce the per-part cost. However, every additional part still consumes significant machine time, so CNC generally does not achieve the same economies of scale as injection molding at higher volumes.

That is fine at low volumes, where there is no tooling investment to offset in the first place. It becomes the limiting factor once volume climbs and a molded process, with its cost concentrated in tooling instead of machine time, starts to look cheaper per part.

Short-run injection molding sits between repeated CNC production and full-scale injection molding.

It uses the same basic molding process as conventional injection molding, but the tooling is designed around a shorter production requirement rather than maximum lifetime.

Depending on the product, manufacturers may use aluminum, softer steels, simplified tooling, inserts, or other rapid-tooling approaches.

A mold represents a larger commitment than updating a machining program, so the design should be reasonably mature before tooling begins.

Before committing, teams should generally have completed major functional testing, selected the intended material, resolved key assembly interfaces, reviewed wall thickness and draft, evaluated undercuts and parting lines, and completed appropriate DFM work.

Critical dimensions should also be defined, and major CAD changes should be slowing down.

That does not mean the product can never change again. It means the remaining changes are unlikely to force a major mold redesign.

If core geometry is still changing regularly, it is usually too early to commit to tooling.

A production mold is built to survive a long tooling life across tens of thousands of cycles. A low-volume tool does not need that. It just needs to produce the units the project actually calls for, without paying for tool life nobody's going to use yet.

Aluminum and other softer tool materials cut machining time and lead time compared to hardened steel, which is why they show up so often in bridge tooling, pilot builds, and early market runs. That said, soft tooling still needs real mold design behind it: gates, runners, vents, cooling, ejection, draft, and shrinkage all still matter.

Material choice affects tool life too. Abrasive or fiber-filled polymers wear a soft tool down faster than an unfilled resin will. The right tooling call still follows the part, not just the lowest tooling quote.

There's no universal number here, whatever a quick search might tell you. The real comparison runs through two rough equations:

CNC total cost = programming and setup + fixtures + (machining cost per part × quantity)

Injection molding total cost = mold cost + setup and validation + (molded cost per part × quantity)

CNC starts cheap on tooling and expensive on repeat cost. Injection molding flips that: a bigger upfront tool, a much lower cost per part once it's running. Where those two lines cross depends on the part. A simple plastic cover might cross over at a lower quantity than a housing that needs side actions, inserts, or difficult tolerances. Get an actual quote against your real geometry before picking a number off a chart.

CNC machining generally carries less commitment when you do not yet know how many units you will need. There is no tooling to write off if demand turns out lower than expected. The exception comes down to geometry and material. A complex plastic part with features only a mold can produce well may still favor short-run molding even under demand uncertainty, because CNC simply cannot deliver the same geometry economically.

If demand is becoming more predictable, short-run injection molding can work as a bridge to larger-scale production. It produces production-material parts while demand develops and can bridge the gap until long-life production tooling becomes justified or is ready.

For a product ultimately intended for injection molding, short-run molding can also provide useful process knowledge around material behavior, shrinkage, part quality, and moldability before the team commits to long-life production tooling.

The unit price on a quote is only one line in a much longer equation. Comparing low volume manufacturing against mass production properly means looking at the full cost picture, not just the number that is easiest to compare.

Tooling cost, setup and programming time, part cost, finishing, inspection, assembly, and the cost of any design revisions all belong in the comparison. So does inventory carrying cost, the risk of scrap or obsolete stock if the design changes, the cost of modifying a tool after the fact, and how production lead time affects your ability to respond to the market. Add those up on both sides before deciding which route is actually cheaper for your situation.

Because every part is a different combination of geometry, material, cavity count, tolerance, and expected life. A simple bracket and a complex, tight-tolerance enclosure will cross over between CNC and molding at completely different quantities, even if you are ordering the same number of units. Anyone offering a single universal breakeven number, five hundred units or a thousand units, is oversimplifying a calculation that depends entirely on your specific part.

For medical devices and other regulated products, manufacturing decisions must align with design controls, risk management, verification, validation, documentation, and eventual design transfer.

That often makes flexibility especially valuable before a team commits to long-life production tooling.

Low-volume builds can support design verification or validation when the units appropriately represent the design, materials, components, and manufacturing conditions required by the documented verification or validation plan. Low production quantity itself does not make a build suitable for these activities.

For US medical devices, FDA's Quality Management System Regulation (QMSR), effective February 2, 2026, incorporates ISO 13485:2016 into 21 CFR Part 820.

For medical device development, working with a partner that follows an ISO 13485:2016-certified quality management process can support the documented controls, traceability, and quality requirements involved in moving from development toward production.

Medical-device design changes must be reviewed and may require additional verification or validation. Depending on the significance of the change and the target market, some changes may also require additional regulatory assessment or submission. This can make committing to production tooling too early a greater risk.

Staying in low volume manufacturing longer gives medical device teams room to finish verification, respond to regulatory feedback, and lock the design with real confidence before investing in production tooling that is expensive to change once it exists.

Low volume manufacturing reduces commitment, but choosing the wrong process at the wrong stage can create unnecessary cost.

The two biggest mistakes sit at opposite ends: investing in tooling before the product is ready, or staying with CNC after the product has clearly outgrown it.

Quantity is one input, not the only one. A team that picks CNC or molding purely based on how many units they need, without factoring in design maturity, part geometry, material requirements, or how likely the design is to change again, often ends up with the wrong process for their actual situation. The right choice weighs quantity alongside all of that, not instead of it.

A mold turns a design decision into physical tooling. Before that point, a change is a CAD update. After it, the same change can mean machining the mold again, adding an insert, or building a new one, on top of whatever schedule delay that causes.

Tool when the design is stable enough to justify that commitment, not simply because the expected quantity looks attractive. This is where teams need to reduce product development risk before committing to tooling.

The opposite mistake is just as real. Once a design has genuinely stabilized and demand has become predictable, continuing to pay CNC's higher per-part cost instead of moving to molding or production tooling starts costing more than it needs to. CNC's strength is flexibility during uncertainty. Once that uncertainty is gone, its cost structure stops working in your favor.

The right process should match the product's current level of certainty.

Instead of asking only, "Which option has the lowest unit price?", ask:

"Which option gives us the right balance of cost, flexibility, quality, and manufacturing commitment at this stage?"

Choose CNC machining when:

1. The design may still change
2. You need relatively small quantities
3. The part requires metal or machinable engineering plastics
4. Tight tolerances or precision features matter
5. Dedicated tooling cannot yet be justified

CNC makes the most sense when flexibility and precision matter more than achieving the lowest possible recurring unit cost.

Choose short-run injection molding when:

1. The plastic part has reached reasonable design stability
2. You need repeatable, production-intent molded parts
3. Repeated machining is becoming expensive
4. Actual molding behavior matters
5. You are not yet ready to invest in long-life production tooling

It works particularly well as a bridge between early low-volume production and larger-scale manufacturing.

Move toward mass production when both the product and the market have matured.

Look for stable CAD and specifications, completed DFM, validated materials, controlled suppliers, repeatable processes, predictable quality requirements, reliable demand forecasts, and enough sustained volume to justify the tooling investment.

The goal is not to reach mass production as early as possible.

It is to reach mass production when the design, manufacturing process, and demand are stable enough to support the commitment.

iMAC Design & Engineering Services works across this range, from early CNC-machined builds through tooling and into contract manufacturing, without handing the project off between separate vendors at each stage. The same engineering team stays on the project from CAD design and DFM review through CNC and VMC machining, tooling development, and injection molding production.

That includes confirmed mold design and injection molding work across the project portfolio, including the Pill Cap medical IoT device. Since 2020, iMAC has delivered 140+ projects for 30+ global clients and operates under ISO 9001:2015 and ISO 13485:2016 certifications.

If low-volume production is starting to look like the safer next step, or you're trying to find where your own breakeven point falls, that's worth a conversation before any tooling gets committed.